1. Home
  2. BHVN vs SYBT Comparison

BHVN vs SYBT Comparison

Compare BHVN & SYBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHVN
  • SYBT
  • Stock Information
  • Founded
  • BHVN 2013
  • SYBT 1904
  • Country
  • BHVN United States
  • SYBT United States
  • Employees
  • BHVN N/A
  • SYBT N/A
  • Industry
  • BHVN Biotechnology: Pharmaceutical Preparations
  • SYBT Major Banks
  • Sector
  • BHVN Health Care
  • SYBT Finance
  • Exchange
  • BHVN Nasdaq
  • SYBT Nasdaq
  • Market Cap
  • BHVN 1.9B
  • SYBT 2.2B
  • IPO Year
  • BHVN 2017
  • SYBT N/A
  • Fundamental
  • Price
  • BHVN $14.45
  • SYBT $74.14
  • Analyst Decision
  • BHVN Strong Buy
  • SYBT Hold
  • Analyst Count
  • BHVN 14
  • SYBT 3
  • Target Price
  • BHVN $58.85
  • SYBT $80.33
  • AVG Volume (30 Days)
  • BHVN 2.1M
  • SYBT 109.2K
  • Earning Date
  • BHVN 08-07-2025
  • SYBT 07-23-2025
  • Dividend Yield
  • BHVN N/A
  • SYBT 1.67%
  • EPS Growth
  • BHVN N/A
  • SYBT 16.29
  • EPS
  • BHVN N/A
  • SYBT 4.14
  • Revenue
  • BHVN N/A
  • SYBT $353,277,000.00
  • Revenue This Year
  • BHVN N/A
  • SYBT $14.39
  • Revenue Next Year
  • BHVN $59.97
  • SYBT $5.04
  • P/E Ratio
  • BHVN N/A
  • SYBT $17.91
  • Revenue Growth
  • BHVN N/A
  • SYBT 8.97
  • 52 Week Low
  • BHVN $13.87
  • SYBT $46.70
  • 52 Week High
  • BHVN $55.70
  • SYBT $79.85
  • Technical
  • Relative Strength Index (RSI)
  • BHVN 33.35
  • SYBT 48.75
  • Support Level
  • BHVN $14.95
  • SYBT $72.76
  • Resistance Level
  • BHVN $17.73
  • SYBT $78.41
  • Average True Range (ATR)
  • BHVN 0.87
  • SYBT 1.68
  • MACD
  • BHVN 0.04
  • SYBT -0.25
  • Stochastic Oscillator
  • BHVN 15.03
  • SYBT 30.46

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

About SYBT Stock Yards Bancorp Inc.

Stock Yards Bancorp Inc operates as a bank. The bank has two reportable operating segments namely Commercial Banking and Wealth Management and Trust. Its services include loan and deposit services, cash management services, securities brokerage activities, mortgage origination, and others. It generates the majority of its revenue from the Commercial Banking segment.

Share on Social Networks: